Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, December 23, 2015
Boehringer Ingelheim will make a significant investment in biopharmaceutical production at its Vienna (Austria) site. There the research-driven pharmaceutical company will establish a new large-scale biopharmaceutical production facility for active ...
read more
Tuesday, October 31, 2017
Boehringer Ingelheim and Sarah Cannon Research Institute announced an expansion of their partnership to develop novel immuno-oncology therapies
read more
Tuesday, November 11, 2014
Boehringer Ingelheim, one of the top 20 global pharma companies, has introduced IDBS’ [2]E-WorkBook Suite to eliminate data silos in the lab. The cross-domain platform has initially been deployed in North America with the next roll-out planned for ...
read more
Boehringer Ingelheim has signed with Zhangjiang Biotech & Pharmaceutical Base Development Company in Pudong, Shanghai a strategic alliance agreement and contract to build a cGMP biopharmaceuticals facility. The new site will provide full range of ...
read more
Wednesday, February 11, 2015
Boehringer Ingelheim, a research-based, global pharmaceutical company, and VTU Technology, a leading contract research and development company, announced today the renewal of their global Pichia pastoris technology collaboration agreement. VTU ...
read more
Boehringer Ingelheim and Gubra announce a second collaboration and license agreement for the development of novel poly-agonist peptides to treat obesity.
read more
Boehringer Ingelheim and Eli Lilly announced a research collaboration with DCRI for the prevention of Chronic heart failure and mortality after an acute Myocardial Infarction.
read more
Boehringer Ingelheim and Eli Lilly announced plans to expand their clinical trial program for empagliflozin in chronic heart failure with the EMPERIAL clinical trials.
read more
Thursday, November 16, 2017
Boehringer Ingelheim and MiNA have signed a collaboration and licensing agreement focused on the development of novel compounds to treat fibrotic liver diseases.
read more
Wednesday, September 23, 2020
Boehringer Ingelheim and Mirati announced a clinical collaboration to evaluate the BI 1701963 and MRTX849 for patients with solid tumors that harbor the KRAS G12C mutation.
read more
TARGET PharmaSolutions announced that Boehringer Ingelheim International GmbH has entered into a multi-year strategic partnership for TARGET-NASH.
read more
Boehringer Ingelheim and the University of Dundee have extended their collaboration to develop new medicines that target and destroy key cancer causing proteins.
read more
For patients, the new Digital Front Door software unlocks interoperability, patient access, data sharing, simplified informed consent process and boosted participant engagement. This leads to better patient retention and a lighter caregiver burden ...
read more
Wednesday, August 28, 2019
Bone Solutions announces a private label licensing agreement with Onkos Surgical covering OsteoCrete® technology designed to assist with bone repair and regeneration.
read more
Thursday, November 21, 2019
Bonum Health, has partnered with Benzer Pharmacy, a Tampa Bay-based chain of independent retail pharmacies, to launch the “Bonum Health Hub.”
read more